piracetam has been researched along with Acute Disease in 46 studies
Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.
Acute Disease: Disease having a short and relatively severe course.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In a prospective randomised clinical study on 39 patients with tinnitus and sudden hearing loss the therapeutic efficacy of piracetam/HAES 6% was compared with that of naftidrofuryl/HAES 6%." | 9.08 | [Piracetam infusions in acute tinnitus and sudden deafness]. ( Gutmann, R; Mees, K, 1995) |
| "There is some suggestion (but no statistically significant result) of an unfavourable effect of piracetam on early death, but this may have been caused by baseline differences in stroke severity in the trials." | 8.88 | Piracetam for acute ischaemic stroke. ( Cantisani, TA; Celani, MG; Ricci, S; Righetti, E, 2012) |
| "Piracetam has neuroprotective and antithrombotic effects which may help to reduce death and disability in people with acute stroke." | 8.83 | Piracetam for acute ischaemic stroke. ( Cantisani, AT; Celani, MG; Ricci, S; Righetti, E, 2006) |
| "The objective of this review was to assess the effects of piracetam in acute presumed ischaemic stroke." | 8.81 | Piracetam for acute ischaemic stroke. ( Cantisani, AT; Celani, MG; Ricci, S; Righetti, E, 2002) |
| "We studied whether the administration of piracetam in acute, presumed ischemic stroke affects case fatality and functional outcome." | 8.80 | Piracetam in acute stroke: a systematic review. ( Cantisani, TA; Celani, MG; Ricci, S; Righetti, E, 2000) |
| "Our previous study showed that treatment with levetiracetam (LEV) after status epilepticus (SE) termination by diazepam might prevent the development of spontaneous recurrent seizures via the inhibition of neurotoxicity induced by brain edema events." | 7.83 | Levetiracetam treatment influences blood-brain barrier failure associated with angiogenesis and inflammatory responses in the acute phase of epileptogenesis in post-status epilepticus mice. ( Chiba, Y; Dohgu, S; Ishihara, Y; Itoh, K; Kataoka, Y; Komori, R; Nochi, H; Takata-Tsuji, F; Taniguchi, R; Ueno, M, 2016) |
| "To clarify the effect of levetiracetam (LEV) for acute and chronic seizure control in acute encephalitis with refractory, repetitive partial seizures (AERRPS)." | 7.81 | Effect of levetiracetam in acute encephalitis with refractory, repetitive partial seizures during acute and chronic phase. ( Imamura, A; Maegaki, Y; Maruta, K; Matsunami, K; Narita, A; Nishimura, Y; Ohno, K; Saiki, Y; Saito, Y; Sokota, T; Sugihara, S; Tamasaki, A; Ueda, R, 2015) |
| " Approximately 30-40% of brain tumors patients who present with status epilepticus (SE) will not respond to typical therapy consisting of benzodiazepines and phenytoin (PHT), resulting in patients with refractory status epilepticus (RSE)." | 7.78 | Phenytoin, levetiracetam, and pregabalin in the acute management of refractory status epilepticus in patients with brain tumors. ( Doreswamy, M; Gingrich, KJ; Kolls, BJ; Swisher, CB; Vredenburgh, JJ, 2012) |
| "In this retrospective study of institutionalized patients with mental retardation, we present the efficacy and safety of sequential treatment with intrarectal diazepam (IRD) gel (Diastat) and intravenous levetiracetam (IVL) in comparison with either treatment alone for acute repetitive or prolonged seizures (ARPS)." | 7.76 | Sequential intrarectal diazepam and intravenous levetiracetam in treating acute repetitive and prolonged seizures. ( Milteer, WE; Modur, PN; Zhang, S, 2010) |
| "Levetiracetam may be effective in children with acute seizures or status epilepticus." | 7.76 | Intravenous levetiracetam in the management of acute seizures in children. ( Huff, AD; Knupp, KG; Reiter, PD; Valuck, RJ, 2010) |
| "Piracetam has been shown to improve speech in aphasic patients." | 6.40 | The role of piracetam in the treatment of acute and chronic aphasia. ( Huber, W, 1999) |
| "We report a patient with focal epilepsy and latent hereditary coproporphyria who had exacerbation of clinical symptoms of porphyria under treatment with valproate and primidone and was then treated with levetiracetam without exacerbation of clinically latent porphyria." | 5.32 | Levetiracetam in focal epilepsy and hepatic porphyria: a case report. ( Meencke, HJ; Paul, F, 2004) |
| "Levetiracetam is a new anticonvulsant (AED) with a novel mechanism of action." | 5.31 | Levetiracetam psychosis in children with epilepsy. ( Bergey, GK; Freeman, JM; Kossoff, EH; Vining, EP, 2001) |
| "In a prospective randomised clinical study on 39 patients with tinnitus and sudden hearing loss the therapeutic efficacy of piracetam/HAES 6% was compared with that of naftidrofuryl/HAES 6%." | 5.08 | [Piracetam infusions in acute tinnitus and sudden deafness]. ( Gutmann, R; Mees, K, 1995) |
| "There is some suggestion (but no statistically significant result) of an unfavourable effect of piracetam on early death, but this may have been caused by baseline differences in stroke severity in the trials." | 4.88 | Piracetam for acute ischaemic stroke. ( Cantisani, TA; Celani, MG; Ricci, S; Righetti, E, 2012) |
| "Piracetam has neuroprotective and antithrombotic effects which may help to reduce death and disability in people with acute stroke." | 4.83 | Piracetam for acute ischaemic stroke. ( Cantisani, AT; Celani, MG; Ricci, S; Righetti, E, 2006) |
| "The objective of this review was to assess the effects of piracetam in acute presumed ischaemic stroke." | 4.81 | Piracetam for acute ischaemic stroke. ( Cantisani, AT; Celani, MG; Ricci, S; Righetti, E, 2002) |
| "We studied whether the administration of piracetam in acute, presumed ischemic stroke affects case fatality and functional outcome." | 4.80 | Piracetam in acute stroke: a systematic review. ( Cantisani, TA; Celani, MG; Ricci, S; Righetti, E, 2000) |
| "Our previous study showed that treatment with levetiracetam (LEV) after status epilepticus (SE) termination by diazepam might prevent the development of spontaneous recurrent seizures via the inhibition of neurotoxicity induced by brain edema events." | 3.83 | Levetiracetam treatment influences blood-brain barrier failure associated with angiogenesis and inflammatory responses in the acute phase of epileptogenesis in post-status epilepticus mice. ( Chiba, Y; Dohgu, S; Ishihara, Y; Itoh, K; Kataoka, Y; Komori, R; Nochi, H; Takata-Tsuji, F; Taniguchi, R; Ueno, M, 2016) |
| "To clarify the effect of levetiracetam (LEV) for acute and chronic seizure control in acute encephalitis with refractory, repetitive partial seizures (AERRPS)." | 3.81 | Effect of levetiracetam in acute encephalitis with refractory, repetitive partial seizures during acute and chronic phase. ( Imamura, A; Maegaki, Y; Maruta, K; Matsunami, K; Narita, A; Nishimura, Y; Ohno, K; Saiki, Y; Saito, Y; Sokota, T; Sugihara, S; Tamasaki, A; Ueda, R, 2015) |
| "Twelve patients received a levetiracetam load of 25 to 50 mg/kg for neonatal seizures." | 3.79 | Role of intravenous levetiracetam for acute seizure management in preterm neonates. ( Cipriani, C; Crisp, E; Khan, O; Kirmani, B; Wright, C, 2013) |
| " Approximately 30-40% of brain tumors patients who present with status epilepticus (SE) will not respond to typical therapy consisting of benzodiazepines and phenytoin (PHT), resulting in patients with refractory status epilepticus (RSE)." | 3.78 | Phenytoin, levetiracetam, and pregabalin in the acute management of refractory status epilepticus in patients with brain tumors. ( Doreswamy, M; Gingrich, KJ; Kolls, BJ; Swisher, CB; Vredenburgh, JJ, 2012) |
| "In this retrospective study of institutionalized patients with mental retardation, we present the efficacy and safety of sequential treatment with intrarectal diazepam (IRD) gel (Diastat) and intravenous levetiracetam (IVL) in comparison with either treatment alone for acute repetitive or prolonged seizures (ARPS)." | 3.76 | Sequential intrarectal diazepam and intravenous levetiracetam in treating acute repetitive and prolonged seizures. ( Milteer, WE; Modur, PN; Zhang, S, 2010) |
| "Levetiracetam may be effective in children with acute seizures or status epilepticus." | 3.76 | Intravenous levetiracetam in the management of acute seizures in children. ( Huff, AD; Knupp, KG; Reiter, PD; Valuck, RJ, 2010) |
| "Fifty-four patients with acute myocardial infarction were evaluated repeatedly, with 28 of those treated with piracetam, and 26 used as controls." | 3.67 | [Therapeutic use of piracetam in myocardial infarct patients]. ( Fedorov, VS; Leshchinskiĭ, LA; Pimenov, LT, 1987) |
| "Levetiracetam is a novel antiepileptic drug with a broad spectrum of efficacy in epilepsy." | 2.71 | Levetiracetam in the treatment of acute mania: an open add-on study with an on-off-on design. ( Born, C; Grunze, H; Langosch, J; Schaub, G; Walden, J, 2003) |
| " Safety was assessed taking into account adverse events including abnormal laboratory test results and mortality." | 2.69 | The clinical safety of high-dose piracetam--its use in the treatment of acute stroke. ( De Reuck, J; Van Vleymen, B, 1999) |
| "Piracetam has been shown to improve speech in aphasic patients." | 2.40 | The role of piracetam in the treatment of acute and chronic aphasia. ( Huber, W, 1999) |
| "Levetiracetam treatment lasted 8 months." | 1.37 | Epileptic seizures after octreotide administration in a 6.5-year-old female with ALL and L-asparaginase associated pancreatitis: a possible drug interaction. ( Athanassiadou, F; Balakou, E; Hatzipantelis, E; Pana, ZD; Papageorgiou, T; Pavlou, E; Tragiannidis, A; Tsotoulidou, V, 2011) |
| "Valproic acid is an effective anti-epileptic medication often used for long-term control of seizure disorders that has been implicated in hematological toxicities, including rare reports of myelodysplasia and acute leukemia." | 1.35 | Translocation-positive acute myeloid leukemia associated with valproic acid therapy. ( Ben-Ezra, J; Massey, GV; Riley, RS; Russell, EC; Williams, DC, 2008) |
| "Stroke is associated with elevation of several proinflammatory cytokines such as tumor necrosis factor alpha (TNF-alpha) and interleukin (IL)-8 that are correlated with central nervous system (CNS) injury." | 1.34 | TNF-alpha and IL-8 in acute stroke and the modulation of these cytokines by antiplatelet agents. ( Al-Bahrani, A; Bakhiet, M; Shaath, H; Taha, S, 2007) |
| "Older patients and patients with brain tumors or strokes were preferentially treated with LEV for prevention and/or management of seizures (all P < or = 0." | 1.34 | Levetiracetam use in critically ill patients. ( Meckler, JM; Privitera, MD; Shutter, LA; Szaflarski, JP; Szaflarski, M; Yates, SL, 2007) |
| "We report a patient with focal epilepsy and latent hereditary coproporphyria who had exacerbation of clinical symptoms of porphyria under treatment with valproate and primidone and was then treated with levetiracetam without exacerbation of clinically latent porphyria." | 1.32 | Levetiracetam in focal epilepsy and hepatic porphyria: a case report. ( Meencke, HJ; Paul, F, 2004) |
| "Levetiracetam is a new anticonvulsant (AED) with a novel mechanism of action." | 1.31 | Levetiracetam psychosis in children with epilepsy. ( Bergey, GK; Freeman, JM; Kossoff, EH; Vining, EP, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (15.22) | 18.7374 |
| 1990's | 9 (19.57) | 18.2507 |
| 2000's | 20 (43.48) | 29.6817 |
| 2010's | 10 (21.74) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Khan, O | 1 |
| Cipriani, C | 1 |
| Wright, C | 1 |
| Crisp, E | 1 |
| Kirmani, B | 1 |
| Ueda, R | 1 |
| Saito, Y | 1 |
| Ohno, K | 1 |
| Maruta, K | 1 |
| Matsunami, K | 1 |
| Saiki, Y | 1 |
| Sokota, T | 1 |
| Sugihara, S | 1 |
| Nishimura, Y | 1 |
| Tamasaki, A | 1 |
| Narita, A | 1 |
| Imamura, A | 1 |
| Maegaki, Y | 1 |
| Itoh, K | 1 |
| Ishihara, Y | 1 |
| Komori, R | 1 |
| Nochi, H | 1 |
| Taniguchi, R | 1 |
| Chiba, Y | 1 |
| Ueno, M | 1 |
| Takata-Tsuji, F | 1 |
| Dohgu, S | 1 |
| Kataoka, Y | 1 |
| Kalinskiĭ, PP | 1 |
| Nazarov, VV | 1 |
| Samarets, NA | 1 |
| Ulitina, MN | 1 |
| Abend, NS | 1 |
| Monk, HM | 1 |
| Licht, DJ | 1 |
| Dlugos, DJ | 1 |
| Modur, PN | 1 |
| Milteer, WE | 1 |
| Zhang, S | 1 |
| Reiter, PD | 1 |
| Huff, AD | 1 |
| Knupp, KG | 1 |
| Valuck, RJ | 1 |
| Ishii, Y | 1 |
| Tanaka, T | 1 |
| Swisher, CB | 1 |
| Doreswamy, M | 1 |
| Gingrich, KJ | 1 |
| Vredenburgh, JJ | 1 |
| Kolls, BJ | 1 |
| Hatzipantelis, E | 1 |
| Pana, ZD | 1 |
| Pavlou, E | 1 |
| Balakou, E | 1 |
| Tsotoulidou, V | 1 |
| Papageorgiou, T | 1 |
| Tragiannidis, A | 1 |
| Athanassiadou, F | 1 |
| Ricci, S | 4 |
| Celani, MG | 4 |
| Cantisani, TA | 2 |
| Righetti, E | 4 |
| Almeida, DM | 1 |
| Jean, MR | 1 |
| Chystsiakova, A | 1 |
| Monahan, E | 1 |
| Oliveira, SB | 1 |
| Monteiro, IM | 1 |
| Cantisani, AT | 2 |
| Ardid, D | 1 |
| Lamberty, Y | 1 |
| Alloui, A | 1 |
| Coudore-Civiale, MA | 1 |
| Klitgaard, H | 1 |
| Eschalier, A | 1 |
| Grunze, H | 1 |
| Langosch, J | 1 |
| Born, C | 1 |
| Schaub, G | 1 |
| Walden, J | 1 |
| Paul, F | 1 |
| Meencke, HJ | 1 |
| Zarubina, IV | 1 |
| Shabanov, PD | 2 |
| Dove, GH | 1 |
| Buchhalter, JR | 1 |
| Cascino, GD | 1 |
| Zhong, SQ | 1 |
| Sun, LJ | 1 |
| Yan, YZ | 1 |
| Sun, YQ | 1 |
| Zhong, YY | 1 |
| Zesiewicz, TA | 1 |
| Pathak, A | 1 |
| Sullivan, KL | 1 |
| Shamayev, M | 1 |
| Hauser, RA | 1 |
| Mula, M | 1 |
| Trimble, MR | 1 |
| Williams, DC | 1 |
| Massey, GV | 1 |
| Russell, EC | 1 |
| Riley, RS | 1 |
| Ben-Ezra, J | 1 |
| Al-Bahrani, A | 1 |
| Taha, S | 1 |
| Shaath, H | 1 |
| Bakhiet, M | 1 |
| Desarkar, P | 1 |
| Das, B | 1 |
| Sinha, VK | 1 |
| Szaflarski, JP | 1 |
| Meckler, JM | 1 |
| Szaflarski, M | 1 |
| Shutter, LA | 1 |
| Privitera, MD | 1 |
| Yates, SL | 1 |
| Thacker, AK | 1 |
| Misra, P | 1 |
| Gupta, PP | 1 |
| Bogolepov, NN | 1 |
| Gusev, EI | 2 |
| Burd, GS | 3 |
| Buklina, SB | 2 |
| Sobczyk, W | 1 |
| Monov, A | 1 |
| Klouchek-Popova, E | 1 |
| Nikolova, M | 1 |
| Iosifov, I | 1 |
| Gutmann, R | 1 |
| Mees, K | 1 |
| De Deyn, PP | 1 |
| Reuck, JD | 1 |
| Deberdt, W | 1 |
| Vlietinck, R | 1 |
| Orgogozo, JM | 2 |
| Gekht, AB | 2 |
| Skvortsova, VI | 1 |
| Selikhova, MV | 1 |
| Pavlov, NA | 1 |
| Bolotov, DA | 1 |
| Beliakov, VV | 1 |
| Vanichkin, AV | 1 |
| Konstantinova, MV | 1 |
| Bogolepova, AN | 1 |
| Kozubski, W | 1 |
| Huber, W | 1 |
| De Reuck, J | 1 |
| Van Vleymen, B | 1 |
| Metternich, FU | 1 |
| Brusis, T | 1 |
| Goldberg, JF | 1 |
| Burdick, KE | 1 |
| Kossoff, EH | 1 |
| Bergey, GK | 1 |
| Freeman, JM | 1 |
| Vining, EP | 1 |
| Buliusin, VIa | 1 |
| Besschetnova, AI | 1 |
| Leshchinskiĭ, LA | 1 |
| Pimenov, LT | 1 |
| Fedorov, VS | 1 |
| Niss, AI | 1 |
| Umanskiĭ, KG | 1 |
| Maksutova, EL | 1 |
| Rudometov, IuP | 1 |
| Sonnet, J | 1 |
| Gini, EK | 1 |
| Cornu, G | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Levetiracetam Treatment of Neonatal Seizures: A Multi-Centre Randomized Blinded Controlled Study of the Efficacy of Oral Levetiracetam as First Line Treatment for Neonatal Seizures in China[NCT02550028] | Phase 1/Phase 2 | 60 participants (Actual) | Interventional | 2015-09-01 | Terminated (stopped due to The study was concluded as planned upon reaching its predetermined endpoint, which included the completion of data collection and achievement of the necessary sample size for statistical significance.) | ||
| Placebo-Controlled Crossover Trial of Levetiracetam on Ethanol Intake[NCT01168687] | 46 participants (Actual) | Interventional | 2008-11-30 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
The primary outcome of this study is to determine the effect of levetiracetam on alcohol consumption as measured by change in # of drinks during each treatment period. (NCT01168687)
Timeframe: During each 14 day treatment period
| Intervention | number of drinks per treatment period (Mean) |
|---|---|
| All Subjects (n = 46) Placebo | 41.2 |
| All Subjects (n = 46) Levetiracetam | 45.4 |
6 reviews available for piracetam and Acute Disease
| Article | Year |
|---|---|
[Pharmacology and clinical results of levetiracetam (E Keppra(®) Tablets), a new antiepileptic drug].
Topics: Acute Disease; Allosteric Regulation; Animals; Anticonvulsants; Calcium; Calcium Channel Blockers; C | 2011 |
Piracetam for acute ischaemic stroke.
Topics: Acute Disease; Brain Ischemia; Fibrinolytic Agents; Humans; Neuroprotective Agents; Piracetam; Rando | 2012 |
Piracetam for acute ischaemic stroke.
Topics: Acute Disease; Brain Ischemia; Humans; Neuroprotective Agents; Piracetam; Stroke | 2002 |
Piracetam for acute ischaemic stroke.
Topics: Acute Disease; Brain Ischemia; Humans; Neuroprotective Agents; Piracetam; Stroke | 2006 |
The role of piracetam in the treatment of acute and chronic aphasia.
Topics: Acute Disease; Aphasia; Cerebrovascular Disorders; Chronic Disease; Humans; Nootropic Agents; Pirace | 1999 |
Piracetam in acute stroke: a systematic review.
Topics: Acute Disease; Clinical Trials as Topic; Humans; Piracetam; Stroke; Time Factors; Treatment Outcome | 2000 |
8 trials available for piracetam and Acute Disease
| Article | Year |
|---|---|
Levetiracetam in the treatment of acute mania: an open add-on study with an on-off-on design.
Topics: Acute Disease; Adult; Anticonvulsants; Bipolar Disorder; Diagnostic and Statistical Manual of Mental | 2003 |
Effect of Xuesaitong soft capsule on hemorrheology and in auxiliarily treating patients with acute cerebral infarction.
Topics: Acute Disease; Adult; Aged; Aspirin; Blood Viscosity; Capsules; Cerebral Infarction; Cytidine Diphos | 2005 |
[Effectiveness of parenteral administration of piracetam in acute and chronic consciousness disorders in cerebral arteriosclerosis].
Topics: Acute Disease; Aged; Chronic Disease; Clinical Trials as Topic; Cognition Disorders; Consciousness D | 1980 |
[Piracetam infusions in acute tinnitus and sudden deafness].
Topics: Acute Disease; Adult; Aged; Female; Hearing Loss, Sudden; Humans; Infusions, Intravenous; Male; Midd | 1995 |
Treatment of acute ischemic stroke with piracetam. Members of the Piracetam in Acute Stroke Study (PASS) Group.
Topics: Acute Disease; Aged; Aged, 80 and over; Brain Ischemia; Cerebrovascular Disorders; Double-Blind Meth | 1997 |
Porównanie skuteczności piracetamu i dekstranu 40 tys. u chorych w podeszlym wieku z niedokrwiennym udarem mózgu.
Topics: Acute Disease; Aged; Brain; Brain Ischemia; Dextrans; Female; Humans; Male; Middle Aged; Neuroprotec | 1998 |
The clinical safety of high-dose piracetam--its use in the treatment of acute stroke.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Cerebrovascular Disorders; Double-Blind Method; Femal | 1999 |
[Efficacy of piracetam treatment of acute viral neuroinfections].
Topics: Acute Disease; Adult; Encephalitis; Female; Humans; Hypersensitivity; Male; Middle Aged; Neurocognit | 1985 |
32 other studies available for piracetam and Acute Disease
| Article | Year |
|---|---|
Role of intravenous levetiracetam for acute seizure management in preterm neonates.
Topics: Acute Disease; Anticonvulsants; Electroencephalography; Female; Humans; Infant; Infant, Newborn; Inf | 2013 |
Effect of levetiracetam in acute encephalitis with refractory, repetitive partial seizures during acute and chronic phase.
Topics: Acute Disease; Adolescent; Adult; Anticonvulsants; Bromides; Child; Chronic Disease; Encephalitis; F | 2015 |
Levetiracetam treatment influences blood-brain barrier failure associated with angiogenesis and inflammatory responses in the acute phase of epileptogenesis in post-status epilepticus mice.
Topics: Acute Disease; Animals; Anticonvulsants; Astrocytes; Blood-Brain Barrier; Brain Edema; Capillary Per | 2016 |
[Peculiarities of treatment of asthenic syndrome in the acute period of ischemic stroke].
Topics: Acute Disease; Aged; Asthenia; Brain Ischemia; Female; Humans; Male; Middle Aged; Nootropic Agents; | 2008 |
Intravenous levetiracetam in critically ill children with status epilepticus or acute repetitive seizures.
Topics: Acute Disease; Adolescent; Anticonvulsants; Child; Child, Preschool; Cohort Studies; Critical Illnes | 2009 |
Sequential intrarectal diazepam and intravenous levetiracetam in treating acute repetitive and prolonged seizures.
Topics: Acute Disease; Administration, Rectal; Adult; Aged; Diazepam; Drug Therapy, Combination; Female; Hum | 2010 |
Intravenous levetiracetam in the management of acute seizures in children.
Topics: Acute Disease; Adolescent; Anticonvulsants; Child; Child, Preschool; Female; Humans; Infant; Infant, | 2010 |
Phenytoin, levetiracetam, and pregabalin in the acute management of refractory status epilepticus in patients with brain tumors.
Topics: Acute Disease; Aged; Anticonvulsants; Brain Neoplasms; Drug Therapy, Combination; Female; gamma-Amin | 2012 |
Epileptic seizures after octreotide administration in a 6.5-year-old female with ALL and L-asparaginase associated pancreatitis: a possible drug interaction.
Topics: Acute Disease; Anticonvulsants; Asparaginase; Child; Diagnosis, Differential; Drug Interactions; Ele | 2011 |
Levetiracetam-associated acute pancreatitis in an adolescent with autism: a case report.
Topics: Acute Disease; Adolescent; Anticonvulsants; Autistic Disorder; Epilepsy; Humans; Levetiracetam; Male | 2013 |
Antihyperalgesic effect of levetiracetam in neuropathic pain models in rats.
Topics: Acute Disease; Analgesics; Animals; Carbamazepine; Chronic Disease; Constriction, Pathologic; Diabet | 2003 |
Levetiracetam in focal epilepsy and hepatic porphyria: a case report.
Topics: Acute Disease; Adult; Anticonvulsants; Comorbidity; Epilepsies, Partial; Female; Humans; Levetiracet | 2004 |
[Significance of individual resistance to hypoxia for the correction of the brain trauma sequelae].
Topics: Acute Disease; Animals; Benzimidazoles; Brain; Brain Injuries; Disease Susceptibility; Hypoxia; Male | 2003 |
Acute repetitive pilomotor seizures (goose bumps) in a patient with right mesial temporal sclerosis.
Topics: Acute Disease; Adult; Electroencephalography; Epilepsy, Temporal Lobe; Female; Humans; Levetiracetam | 2004 |
Treatment of chorea with levetiracetam.
Topics: Acute Disease; Adult; Anticonvulsants; Chorea; Diabetes Mellitus, Type 1; Female; Humans; Levetirace | 2006 |
Re: Drug-induced psychosis with levetiracetam.
Topics: Acute Disease; Anticonvulsants; Humans; Levetiracetam; Piracetam; Psychoses, Substance-Induced; Seiz | 2005 |
Translocation-positive acute myeloid leukemia associated with valproic acid therapy.
Topics: Acute Disease; Anticonvulsants; Cell Differentiation; Cell Division; Child, Preschool; Chromosomes, | 2008 |
TNF-alpha and IL-8 in acute stroke and the modulation of these cytokines by antiplatelet agents.
Topics: Acute Disease; Adult; Aged; Aspirin; Brain Ischemia; Cells, Cultured; Clopidogrel; Dipyridamole; Fem | 2007 |
Adjuvant levetiracetam in adolescent mania.
Topics: Acute Disease; Adolescent; Anticonvulsants; Bipolar Disorder; Dose-Response Relationship, Drug; Fema | 2007 |
Levetiracetam use in critically ill patients.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Anticonvulsants; Brain Diseases; Brain Ne | 2007 |
Exacerbations of seizures by levetiracetam.
Topics: Acute Disease; Adult; Dose-Response Relationship, Drug; Epilepsy; Epilepsy, Complex Partial; Female; | 2008 |
[Ultrastructural aspects of acute cerebral ischemia during nootropil administration (experimental study)].
Topics: Acute Disease; Animals; Brain Ischemia; Cerebral Cortex; Energy Metabolism; Nerve Degeneration; Nerv | 1983 |
[Experimental studies of the effect of a single administration of nootropil in acute imipramine poisoning].
Topics: Acute Disease; Animals; Antidotes; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; I | 1982 |
[The metabolic therapy of ischemic stroke: the use of nootropil].
Topics: Acute Disease; Brain Ischemia; Combined Modality Therapy; Dose-Response Relationship, Drug; Drug Eva | 1997 |
[Nootropil in the treatment of disorders of the higher mental functions in patients with an ischemic stroke].
Topics: Acute Disease; Aged; Brain Ischemia; Combined Modality Therapy; Dominance, Cerebral; Female; Higher | 1997 |
Piracetam in the treatment of acute stroke.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Aphasia; Cerebrovascular Disorders; Female; Humans; M | 1999 |
[Acute hearing loss and tinnitus caused by amplified recreational music].
Topics: Acute Disease; Adolescent; Adult; Audiometry, Pure-Tone; Dose-Response Relationship, Drug; Drug Ther | 1999 |
Levetiracetam for acute mania.
Topics: Acute Disease; Adult; Bipolar Disorder; Dose-Response Relationship, Drug; Drug Administration Schedu | 2002 |
Levetiracetam psychosis in children with epilepsy.
Topics: Acute Disease; Adolescent; Anticonvulsants; Child, Preschool; Comorbidity; Drug Administration Sched | 2001 |
[Hyperbaric oxygenation and nootropic agents in the treatment of exacerbation of peptic ulcer].
Topics: Acute Disease; Adult; Central Nervous System Agents; Combined Modality Therapy; Etimizol; Female; Hu | 1987 |
[Therapeutic use of piracetam in myocardial infarct patients].
Topics: Acute Disease; Analgesics; Angina Pectoris; Blood Pressure; Clinical Enzyme Tests; Coronary Circulat | 1987 |
[Trial prevention of vaso-occlusive crises in homozygote sickle cell anemia using piracetam].
Topics: Acute Disease; Adolescent; Adult; Anemia, Sickle Cell; Child; Child, Preschool; Drug Evaluation; Hum | 1985 |